RBC Capital analyst Arun Viswanathan raised the firm’s price target on Corteva to $78 from $72 and keeps an Outperform rating on the shares after its smaller than expected Q3 earnings loss. The company is well positioned to benefit from macro and company specific self-help action despite market driven cost inflation, the analyst tells investors in a research note. Viswanathan adds that he is positive on the ag market and Corteva given the company’s strong visibility and its "somewhat recession proof nature".
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CTVA: